Gabather AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 2014-01-01
- Employees
- 3
- Market Cap
- -
- Website
- http://www.gabather.com
Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Safety and Tolerability
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2019-01-25
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Gabather AB
- Target Recruit Count
- 32
- Registration Number
- NCT03817346
- Locations
- 🇫🇮
CRST Oy, Clinical Research Services Turku, Turku, Finland
© Copyright 2025. All Rights Reserved by MedPath